MM

Matthew W. Martin

FT Forma Therapeutics: 50 patents #2 of 86Top 3%
AM Amgen: 10 patents #315 of 2,867Top 15%
VH Valo Health: 8 patents #9 of 53Top 20%
VD Valo Early Discovery: 5 patents #11 of 30Top 40%
HI H. Lee Moffitt Cancer Center And Research Institute: 1 patents #146 of 269Top 55%
TU Trustees Of Indiana University: 1 patents #114 of 337Top 35%
📍 Indianapolis, IN: #18 of 5,011 inventorsTop 1%
🗺 Indiana: #128 of 33,936 inventorsTop 1%
Overall (All Time): #26,123 of 4,157,543Top 1%
74
Patents All Time

Issued Patents All Time

Showing 26–50 of 74 patents

Patent #TitleCo-InventorsDate
10793554 Solid forms of 4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl)piperazin-1-yl)(1-hydroxycyclopropyl)methanone George P. Luke, Stephen Hubbs, Robert Wenslow, Yawei Shi, Jun Huang 2020-10-06
10703764 Benzopiperazine compositions as BET bromodomain inhibitors Kenneth W. Bair, Torsten Herbertz, Goss S. Kauffman, Katherine J. Kayser-Bricker, George P. Luke +4 more 2020-07-07
10611750 Tetrahydroquinoline compositions as bet bromodomain inhibitors Kenneth W. Bair, Torsten Herbertz, Goss S. Kauffman, Katherine J. Kayser-Bricker, George P. Luke +3 more 2020-04-07
10538496 Methods using HDAC11 inhibitors Jennifer Lee, Pearlie Burnette, Srikumar Chellappan, Nicholas Barczak, Jaime Escobedo +8 more 2020-01-21
10513501 3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki +5 more 2019-12-24
10508088 Methods using HDAC11 inhibitors Jennifer Lee, Nicholas Barczak, Jaime Escobedo, Chiara Conti, Bingsong Han +6 more 2019-12-17
10508077 Alpha-cinnamide compounds and compositions as HDAC8 inhibitors Kenneth W. Bair, Nicholas Barczak, Bingsong Han, David R. Lancia, Jr., Cuixian Liu +5 more 2019-12-17
10501424 3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki +4 more 2019-12-10
10494354 3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki +4 more 2019-12-03
10494353 3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki +4 more 2019-12-03
10494352 3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki +4 more 2019-12-03
10494351 3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki +4 more 2019-12-03
10479772 3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki +4 more 2019-11-19
10472342 Compounds and compositions for inhibition of FASN Kenneth W. Bair, David R. Lancia, Jr., Hongbin Li, James Loch, Wei Lu +3 more 2019-11-12
10472337 3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki +4 more 2019-11-12
10464910 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki +6 more 2019-11-05
10464909 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki +6 more 2019-11-05
10457652 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki +6 more 2019-10-29
10457655 Compounds and compositions for inhibition of FASN Kenneth W. Bair, David R. Lancia, Jr., Hongbin Li, James Loch, Wei Lu +3 more 2019-10-29
10450286 Compounds and compositions for inhibition of FASN Kenneth W. Bair, David R. Lancia, Jr., Hongbin Li, James Loch, Wei Lu +3 more 2019-10-22
10450283 3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki +5 more 2019-10-22
10450284 3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki +4 more 2019-10-22
10442776 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki +6 more 2019-10-15
10428031 3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki +5 more 2019-10-01
10421731 3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki +5 more 2019-09-24